AngioScore, Inc. v. TriReme Medical, LLC

  1. July 21, 2016

    Fed. Circ. Kills $20M AngioScore Win For Jurisdiction Flub

    The Federal Circuit on Thursday scrapped AngioScore Inc.'s $20 million win on breach of duty claims against a former board member and rival TriReme Medical LLC over a heart catheter design, ruling the California state law claim never should have been heard in federal court.

  2. June 07, 2016

    AngioScore's $20M Award Came In Wrong Suit, Fed. Circ. Told

    TriReme Medical LLC told a Federal Circuit panel Tuesday that competitor AngioScore Inc. had no business bringing unrelated state law claims in a federal patent case and urged the panel to overturn the decision that led to a $20 million judgment.

  3. February 17, 2016

    TriReme Asks Fed. Circ. To Nix $20M Catheter IP Suit

    TriReme Medical Inc. and two other companies urged the Federal Circuit on Tuesday to reverse a Delaware federal court's interpretation of state law that led to their being on the hook for $20 million in past and future profits to AngioScore Inc. over one of its founder's heart catheter designs.

  4. October 28, 2015

    TriReme Takes $20M Catheter IP Loss To Fed. Circ.

    TriReme Medical urged the Federal Circuit Tuesday to consider whether it has to immediately pay a $20 million judgment to rival AngioScore over a heart catheter design, saying a California federal judge's decision not to halt the payout while the appeal proceeds could drive the company into bankruptcy.